Edaravone

EDARACUT®

Edaravone 30 mg, solution for injection


How supplied:

Package containig 10 ampoules of 20 ml each.


Indications:

EDARACUT® is indicated to improve the neurological symptoms  and motor disorders  secondary to acute ischaemic stroke (AIS)

EDARACUT® is indicated for the treatment of amyotrophic lateral sclerosis (ALS)


Dose and administration:

AIS:The recommended adult dosage is 30 mg of Edaracut®, intravenously over 30 minutes, twice a day in the morning and the evening.

The administration should be initiated within 24 hours after the onset of the symptoms and cannot exceed 14 days.

ALS: The recommended dosage is 60 mg administered as an intravenous infusion over 60 minutes as follows:

-First cycle: daily dosing for 14 days followed by a 14-day drug-free period; 

-Subsequent cycles: daily dosing for 10 days out of 14-day periods, followed by 14-day drug-free periods.


Storage:

Store in its original package at room temperature below 25°C. 

Encarnación Ezcurra 365 Piso 3, C1107CLA, Buenos Aires, Argentina - Phone/Fax: 54 11 5787 2222